Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
Published
Moderna 's new Covid vaccine produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday. The updated shot produced an 8.7-fold increase in protective…
#ba286 #moderna #fl151 #stephenhoge #cdc